Concepedia

Marianne Riepenhausen

MR

15

Publications

1.2K

Citations

15

H-Index

1984

Active since

Affiliations

University Hospital Münster(Current)

University of Münster

Uniwersytecki Szpital Dziecięcy

Helios Hospital Berlin-Buch

Heinrich Heine University Düsseldorf

Marianne Riepenhausen is an author at University Hospital Münster specializing in engineering, pediatrics, and medicine.

Top concepts

Publications per year

1984–2022

15

Publications

15

High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90

G. Schellong, Richard Pötter, Jürgen Brämswig et al. · Journal of Clinical Oncology · 1999 · 248 citations

Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies

G. Schellong, Marianne Riepenhausen, Christian Bruch et al. · Pediatric Blood & Cancer · 2010 · 171 citations

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.

R. Rossi, Almut Gödde, Almud Kleinebrand et al. · Journal of Clinical Oncology · 1994 · 135 citations

Salvage Therapy of Progressive and Recurrent Hodgkin’s Disease: Results From a Multicenter Study of the Pediatric DAL/GPOH-HD Study Group

G. Schellong, W Dörffel, Alexander Claviez et al. · Journal of Clinical Oncology · 2005 · 127 citations · Full text

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.

G. Schellong, Marianne Riepenhausen, Ursula Creutzig et al. · Journal of Clinical Oncology · 1997 · 83 citations

Rows per page

1–5 of 15